"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLES
Executive Vice President Global, Strategy and Analysis, AdvaMed
Chief Executive Officer, MedTech Europe
President & CEO, Medtech Canada
Director, Business Development, IQVIA MedTech
MedTech in Flux: Navigating Global Disruption
The MedTech industry is at a critical juncture with the global impact of U.S. tariffs and shifting trade dynamics. Hosted by IQVIA MedTech and featuring expert insights from regional trade associations AdvaMed, MedTech Canada and MedTech Europe - this webinar provides valuable insights into the global risks of U.S. tariffs and shifting trade dynamics on MedTech, and strategies medical device companies can adopt to mitigate these risks.
See video timecodes below:
00:00:00 – Webinar Introduction
Matt Stewart opens the webinar by introducing our speakers and the context for the webinar.
00:02:17 – MedTech Sector recent challenges
Ashley Miller, Nicole DeKort, and Oliver Bisazza begin the conversation by discussing the approach to tariffs by the U.S, Canada and the EU, the uncertainties, and the potential downstream effects.
00:07:31 – The impact of tariffs on medical device companies
Our panel explores why tariffs have more of a direct and immediate impact on medical device companies compared to the pharmaceutical industry.
00:14:00 – Key concerns driving the need for medical device tariff exemptions
Our panel call for “zero-for-zero” tariff agreements in MedTech and explain the reasons for why this is so important.
00:29:12 – Strategies for mitigating risks
In this section we explore the projected cost of tariffs on the MedTech industry, which countries will be impacted the most, and the actions that need to be taken now to navigate the disruption.
You can download the presentation here.
If you wish to speak with our IQVIA MedTech team, please click the “CONTACT US” button floating on this page to make an enquiry.
Forging a path for MedTech Innovation.
Connected commercial solutions, maximizing market performance.
